Mohammad Amjad Kamal

Conformational energy basin mapping and quantum interaction profiling reveal a persistent KRAS-bound small molecule with enhanced binding stability.

KRAS is a major oncogenic target in precision oncology because of its conformational flexibility and limited druggability. This study employed an integrated multiscale computational strategy to identify and characterize novel KRAS inhibitors with improved structural, thermodynamic, and electronic stability. Virtual scr...